Intravenous immunoglobulin therapy in intractable childhood epilepsy: Open-label study and review of the literature

Abstract Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new antiepileptics and to determine the predictors of a favorable response in a prospective open-label add-on study. Of thirty-seven 9.9 ± 0.9-yea...

Full description

Saved in:
Bibliographic Details
Published inEpilepsy & behavior Vol. 17; no. 1; pp. 90 - 94
Main Authors Mikati, Mohamad A, Kurdi, Rana, El-Khoury, Ziad, Rahi, Amal, Raad, Wissam
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2010
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Abstract Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new antiepileptics and to determine the predictors of a favorable response in a prospective open-label add-on study. Of thirty-seven 9.9 ± 0.9-year-old patients (11 with partial seizures, 26 with generalized seizures of whom 9 had West syndrome and 17 Lennox–Gastaut syndrome) followed for 15 ± 3 months, 43% had a >50% decrease in seizures (including 15% seizure free, 229 ± 58 compared with 104 ± 3 seizures/month, P = 0.035: generalized 246 ± 318 to 117 ± 200, P = 0.025, partial 191 ± 437 to 72 ± 179, P > 0.05; power = 0.2). Males were more likely to respond than females ( P = 0.011, odds ratio = 9.3). Review of the literature revealed nine other articles reporting efficacy of IVIG against epileptic seizures. Only one other used statistical methods and, unlike ours, showed only a trend toward seizure frequency reduction without achieving statistical significance, presumably because it was underpowered. These results indicate large-scale controlled studies of IVIG in epilepsy are still needed.
AbstractList Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new antiepileptics and to determine the predictors of a favorable response in a prospective open-label add-on study. Of thirty-seven 9.9+/-0.9-year-old patients (11 with partial seizures, 26 with generalized seizures of whom 9 had West syndrome and 17 Lennox-Gastaut syndrome) followed for 15+/-3 months, 43% had a >50% decrease in seizures (including 15% seizure free, 229+/-58 compared with 104+/-3 seizures/month, P=0.035: generalized 246+/-318 to 117+/-200, P=0.025, partial 191+/-437 to 72+/-179, P>0.05; power=0.2). Males were more likely to respond than females (P=0.011, odds ratio=9.3). Review of the literature revealed nine other articles reporting efficacy of IVIG against epileptic seizures. Only one other used statistical methods and, unlike ours, showed only a trend toward seizure frequency reduction without achieving statistical significance, presumably because it was underpowered. These results indicate large-scale controlled studies of IVIG in epilepsy are still needed.
Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new antiepileptics and to determine the predictors of a favorable response in a prospective open-label add-on study. Of thirty-seven 9.9 ± 0.9-year-old patients (11 with partial seizures, 26 with generalized seizures of whom 9 had West syndrome and 17 Lennox–Gastaut syndrome) followed for 15 ± 3 months, 43% had a >50% decrease in seizures (including 15% seizure free, 229 ± 58 compared with 104 ± 3 seizures/month, P = 0.035: generalized 246 ± 318 to 117 ± 200, P = 0.025, partial 191 ± 437 to 72 ± 179, P > 0.05; power = 0.2). Males were more likely to respond than females ( P = 0.011, odds ratio = 9.3). Review of the literature revealed nine other articles reporting efficacy of IVIG against epileptic seizures. Only one other used statistical methods and, unlike ours, showed only a trend toward seizure frequency reduction without achieving statistical significance, presumably because it was underpowered. These results indicate large-scale controlled studies of IVIG in epilepsy are still needed.
Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new antiepileptics and to determine the predictors of a favorable response in a prospective open-label add-on study. Of thirty-seven 9.9+/-0.9-year-old patients (11 with partial seizures, 26 with generalized seizures of whom 9 had West syndrome and 17 Lennox-Gastaut syndrome) followed for 15+/-3 months, 43% had a >50% decrease in seizures (including 15% seizure free, 229+/-58 compared with 104+/-3 seizures/month, P=0.035: generalized 246+/-318 to 117+/-200, P=0.025, partial 191+/-437 to 72+/-179, P>0.05; power=0.2). Males were more likely to respond than females (P=0.011, odds ratio=9.3). Review of the literature revealed nine other articles reporting efficacy of IVIG against epileptic seizures. Only one other used statistical methods and, unlike ours, showed only a trend toward seizure frequency reduction without achieving statistical significance, presumably because it was underpowered. These results indicate large-scale controlled studies of IVIG in epilepsy are still needed.
Abstract Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new antiepileptics and to determine the predictors of a favorable response in a prospective open-label add-on study. Of thirty-seven 9.9 ± 0.9-year-old patients (11 with partial seizures, 26 with generalized seizures of whom 9 had West syndrome and 17 Lennox–Gastaut syndrome) followed for 15 ± 3 months, 43% had a >50% decrease in seizures (including 15% seizure free, 229 ± 58 compared with 104 ± 3 seizures/month, P = 0.035: generalized 246 ± 318 to 117 ± 200, P = 0.025, partial 191 ± 437 to 72 ± 179, P > 0.05; power = 0.2). Males were more likely to respond than females ( P = 0.011, odds ratio = 9.3). Review of the literature revealed nine other articles reporting efficacy of IVIG against epileptic seizures. Only one other used statistical methods and, unlike ours, showed only a trend toward seizure frequency reduction without achieving statistical significance, presumably because it was underpowered. These results indicate large-scale controlled studies of IVIG in epilepsy are still needed.
Author Raad, Wissam
El-Khoury, Ziad
Mikati, Mohamad A
Kurdi, Rana
Rahi, Amal
Author_xml – sequence: 1
  fullname: Mikati, Mohamad A
– sequence: 2
  fullname: Kurdi, Rana
– sequence: 3
  fullname: El-Khoury, Ziad
– sequence: 4
  fullname: Rahi, Amal
– sequence: 5
  fullname: Raad, Wissam
BackLink https://www.ncbi.nlm.nih.gov/pubmed/20004620$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtvFDEQhC0URB7wC5CQb5xmadvz2EUCKYogiRQpB-Bs-dHDevHYgz0TNP8eDxty4MLJrVZVWf3VOTkJMSAhrxlsGLD23WGzoMb9hgPsymYDHJ6RM9bwpmqg3Z08zQ2ckvOcDwCMNYK9IKfFAnXL4Yzk2zAl9YAhzpm6YZhD_O6jnr0LdNpjUuNCy-hWlZmU9kjN3nm7j9FSHJ3HMS_v6f2IofJKo6d5mu1CVbA04YPDXzT2axL1bipx05zwJXneK5_x1eN7Qb59_vT16qa6u7--vbq8q0zd7aaqQ921UPdWqY5x1WohhBV9Y7e673itOrRWodW6Zc22qWvTGzS8brBjtuYaxQV5e8wdU_w5Y57k4LJB71XAcq7shNhud5zzohRHpUkx54S9HJMbVFokA7nClgf5B7ZcYa_LAru43jzmz3pA--T5S7cIPhwFWK4sLJLMxmEwaF1CM0kb3X8--PiP35RenFH-By6YD3FOoQCUTGYuQX5Z-17rhh1AC7wTvwH_wqsu
CitedBy_id crossref_primary_10_1111_j_1651_2227_2010_01967_x
crossref_primary_10_2174_1570159X20666220706102708
crossref_primary_10_1016_j_neurol_2012_05_014
crossref_primary_10_1038_nrneurol_2010_178
crossref_primary_10_1016_j_recqb_2016_02_003
crossref_primary_10_1016_j_yebeh_2019_04_042
crossref_primary_10_1002_14651858_CD008557_pub3
crossref_primary_10_1002_14651858_CD008557_pub4
crossref_primary_10_1016_j_nrl_2017_09_005
crossref_primary_10_1038_s41598_024_63541_7
crossref_primary_10_3109_00207454_2011_639470
crossref_primary_10_1016_j_yebeh_2020_107665
crossref_primary_10_1016_j_nrleng_2017_09_003
crossref_primary_10_1016_j_eplepsyres_2020_106325
crossref_primary_10_3389_fncel_2014_00362
crossref_primary_10_1007_s10309_022_00538_0
crossref_primary_10_1097_j_pain_0000000000001791
crossref_primary_10_1080_14656566_2023_2215924
crossref_primary_10_17650_2222_8721_2019_9_1_32_51
crossref_primary_10_1517_14740338_2015_1010508
crossref_primary_10_1684_epd_2016_0791
crossref_primary_10_1038_s10038_019_0641_1
crossref_primary_10_4137_CMPed_S38337
crossref_primary_10_1016_j_spen_2016_06_001
crossref_primary_10_1016_j_yebeh_2014_01_017
crossref_primary_10_1016_j_jns_2016_07_001
crossref_primary_10_1016_j_pediatrneurol_2014_11_011
crossref_primary_10_1016_j_spen_2011_06_002
crossref_primary_10_1097_PCC_0000000000002786
crossref_primary_10_1007_s12016_015_8499_2
crossref_primary_10_1016_j_spen_2010_10_007
crossref_primary_10_1016_j_pediatrneurol_2012_03_015
crossref_primary_10_1017_S0317167100015304
crossref_primary_10_1007_s10072_017_3188_y
crossref_primary_10_1007_s11064_018_2700_y
crossref_primary_10_1016_j_seizure_2020_09_015
crossref_primary_10_1111_j_1528_1167_2011_03036_x
crossref_primary_10_1016_j_tins_2012_11_008
Cites_doi 10.1055/s-2008-1071468
10.1179/016164106X98143
10.1016/j.jcv.2006.05.009
10.1016/S0140-6736(02)08446-5
10.1111/j.1528-1157.1997.tb01740.x
10.1016/S0022-3476(05)80900-X
10.1016/S0887-8994(01)00402-7
10.2165/00148581-200507060-00006
10.1016/S0887-8994(97)00157-4
10.1007/s10072-003-0086-2
10.1007/BF01954498
10.1111/j.1528-1157.2000.tb00257.x
10.1177/08830738030180061001
10.1016/S0387-7604(87)80117-1
10.1111/j.1468-1331.2008.02246.x
10.1007/BF02592447
10.1111/j.1528-1167.2007.01134.x
10.1111/j.1528-1167.2008.01891.x
10.1016/j.bbi.2008.03.009
ContentType Journal Article
Copyright Elsevier Inc.
2009 Elsevier Inc.
2009 Elsevier Inc. All rights reserved.
Copyright_xml – notice: Elsevier Inc.
– notice: 2009 Elsevier Inc.
– notice: 2009 Elsevier Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.yebeh.2009.10.020
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1525-5069
EndPage 94
ExternalDocumentID 10_1016_j_yebeh_2009_10_020
20004620
S1525505009006027
1_s2_0_S1525505009006027
Genre Clinical Trial
Journal Article
Review
GroupedDBID -
0R
1
1-
1B1
1P
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P
AACTN
AADPK
AAEDT
AAIAV
AAIKJ
AAKOC
AALMO
AALRI
AAOAW
AAPBV
AAQFI
AAQXK
AAXLA
AAXUO
ABBQC
ABCQJ
ABFLS
ABFNM
ABFRF
ABIVO
ABLVK
ABMAC
ABMZM
ABPIF
ABPTK
ABQIS
ABTEW
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACRLP
ADALY
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AEVXI
AFCTW
AFKWA
AFRHN
AFTJW
AFXIZ
AGHFR
AGUBO
AGWIK
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJUYK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
ASPBG
AVWKF
AZFZN
BKOJK
BLXMC
BNPGV
CAG
COF
CS3
DM4
DU5
EBS
EFBJH
EFJIC
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FO
G-
G-Q
GBLVA
HVGLF
HZ
IHE
IPNFZ
J1W
K
KOM
LCYCR
LG5
M
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SCC
SCU
SDF
SDG
SDP
SES
SEW
SPCBC
SSH
SSN
SSZ
T5K
UHS
UNMZH
XPP
Z5R
ZGI
ZMT
ZU3
---
--K
--M
.1-
.FO
.~1
0R~
1P~
8P~
AAEDW
ABJNI
ADFGL
ADMUD
AXJTR
EFLBG
FYGXN
HZ~
OP~
~G-
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
ID FETCH-LOGICAL-c479t-7eb7604fdaa712a6b333d3f5d8bf724a7eddaedbb6158544cfcec245e71d42be3
IEDL.DBID AIKHN
ISSN 1525-5050
IngestDate Sat Aug 17 02:57:21 EDT 2024
Thu Sep 26 15:56:21 EDT 2024
Sat Sep 28 07:46:24 EDT 2024
Fri Feb 23 02:23:27 EST 2024
Thu Aug 18 17:14:53 EDT 2022
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Therapy
West syndrome
Infantile spasms
Epilepsy
Generalized seizures
Lennox–Gastaut syndrome
Child
Partial seizures
Intravenous gamma globulin
Language English
License 2009 Elsevier Inc. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c479t-7eb7604fdaa712a6b333d3f5d8bf724a7eddaedbb6158544cfcec245e71d42be3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
ObjectType-Review-3
content type line 23
PMID 20004620
PQID 733889222
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_733889222
crossref_primary_10_1016_j_yebeh_2009_10_020
pubmed_primary_20004620
elsevier_sciencedirect_doi_10_1016_j_yebeh_2009_10_020
elsevier_clinicalkeyesjournals_1_s2_0_S1525505009006027
PublicationCentury 2000
PublicationDate 2010-01-01
PublicationDateYYYYMMDD 2010-01-01
PublicationDate_xml – month: 01
  year: 2010
  text: 2010-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Epilepsy & behavior
PublicationTitleAlternate Epilepsy Behav
PublicationYear 2010
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References Elovaara, Apostolski, van Doorn (bib1) 2008; 15
Lagae, Silberstein, Gillis, Casaer (bib13) 1998; 18
Türkay, Baskin, Dener, Gültekin, Tanzer, Sekreter (bib3) 1996; 38
Billiau, Witters, Ceulemans, Kasran, Wouters, Lagae (bib4) 2007; 48
Vezzani, Balosso, Ravizza (bib20) 2008; 22
Van Engelen, Renier, Weemaes, Strengers, Bernsen, Notermans (bib10) 1994; 153
Mikati, Saab (bib14) 2000; 41
Finberg, Newburger, Mikati, Heller, Burns (bib16) 1992; 120
Wang, Lei, Huang (bib19) 2006; 37
Fayad, Choueiri, Mikati (bib12) 1997; 38
Van Rijckevorsel-Harmant, Delire, Schmitz-Moorman, Wieser (bib2) 1994; 24
Kramer, Sagi, Goldberg-Stern, Zelnik, Nissenkorn, Ben-Zeev (bib15) 2009; 50
Mikati, Saab, Fayad, Choueiri (bib21) 2002; 26
Bingel, Pinter, Sotero de Menezes, Rho (bib5) 2003; 18
Tarnow-Mordi, Cust, Brocklehurst, Mohan, Isaacs (bib17) 2002; 359
Ariizumi, Baba, Hibio (bib8) 1987; 9
Espinosa Zacarías, Gutiérrez Moctezuma, Villegas Peña, Olmos G De Alba (bib11) 2002; 34
Granata (bib6) 2003; 24
Janke, Yong (bib18) 2006; 28
Mikati, Shamseddine (bib7) 2005; 7
Illum, Taudorf, Heilmann (bib9) 1990; 21
Lagae (10.1016/j.yebeh.2009.10.020_bib13) 1998; 18
Wang (10.1016/j.yebeh.2009.10.020_bib19) 2006; 37
Mikati (10.1016/j.yebeh.2009.10.020_bib7) 2005; 7
Janke (10.1016/j.yebeh.2009.10.020_bib18) 2006; 28
Bingel (10.1016/j.yebeh.2009.10.020_bib5) 2003; 18
Mikati (10.1016/j.yebeh.2009.10.020_bib14) 2000; 41
Illum (10.1016/j.yebeh.2009.10.020_bib9) 1990; 21
Mikati (10.1016/j.yebeh.2009.10.020_bib21) 2002; 26
Vezzani (10.1016/j.yebeh.2009.10.020_bib20) 2008; 22
Van Rijckevorsel-Harmant (10.1016/j.yebeh.2009.10.020_bib2) 1994; 24
Kramer (10.1016/j.yebeh.2009.10.020_bib15) 2009; 50
Finberg (10.1016/j.yebeh.2009.10.020_bib16) 1992; 120
Billiau (10.1016/j.yebeh.2009.10.020_bib4) 2007; 48
Ariizumi (10.1016/j.yebeh.2009.10.020_bib8) 1987; 9
Tarnow-Mordi (10.1016/j.yebeh.2009.10.020_bib17) 2002; 359
Türkay (10.1016/j.yebeh.2009.10.020_bib3) 1996; 38
Espinosa Zacarías (10.1016/j.yebeh.2009.10.020_bib11) 2002; 34
Granata (10.1016/j.yebeh.2009.10.020_bib6) 2003; 24
Fayad (10.1016/j.yebeh.2009.10.020_bib12) 1997; 38
Elovaara (10.1016/j.yebeh.2009.10.020_bib1) 2008; 15
Van Engelen (10.1016/j.yebeh.2009.10.020_bib10) 1994; 153
References_xml – volume: 38
  start-page: 301
  year: 1996
  end-page: 305
  ident: bib3
  article-title: Immune globulin treatment in intractable epilepsy of childhood
  publication-title: Turk J Pediatr
  contributor:
    fullname: Sekreter
– volume: 48
  start-page: 1739
  year: 2007
  end-page: 1749
  ident: bib4
  article-title: Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile
  publication-title: Epilepsia
  contributor:
    fullname: Lagae
– volume: 24
  start-page: 162
  year: 1994
  end-page: 166
  ident: bib2
  article-title: Treatment of refractory epilepsy with intravenous immunoglobulins: results of the first double-blind/dose finding clinical study
  publication-title: Int J Clin Lab Res
  contributor:
    fullname: Wieser
– volume: 34
  start-page: 816
  year: 2002
  end-page: 819
  ident: bib11
  article-title: Intravenous treatment with immunoglobulins in epileptic syndromes which are difficult to control
  publication-title: Rev Neurol
  contributor:
    fullname: Olmos G De Alba
– volume: 26
  start-page: 298
  year: 2002
  end-page: 300
  ident: bib21
  article-title: Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome
  publication-title: Pediatr Neurol.
  contributor:
    fullname: Choueiri
– volume: 7
  start-page: 377
  year: 2005
  end-page: 389
  ident: bib7
  article-title: Management of Landau–Kleffner syndrome
  publication-title: Paediatr Drugs
  contributor:
    fullname: Shamseddine
– volume: 15
  start-page: 893
  year: 2008
  end-page: 908
  ident: bib1
  article-title: EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
  publication-title: Eur J Neurol
  contributor:
    fullname: van Doorn
– volume: 50
  start-page: 1517
  year: 2009
  end-page: 1524
  ident: bib15
  article-title: Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES)
  publication-title: Epilepsia
  contributor:
    fullname: Ben-Zeev
– volume: 37
  start-page: 47
  year: 2006
  end-page: 52
  ident: bib19
  article-title: Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis
  publication-title: J Clin Virol
  contributor:
    fullname: Huang
– volume: 9
  start-page: 422
  year: 1987
  end-page: 425
  ident: bib8
  article-title: Immunoglobulin therapy in the West syndrome
  publication-title: Brain Dev
  contributor:
    fullname: Hibio
– volume: 21
  start-page: 87
  year: 1990
  end-page: 90
  ident: bib9
  article-title: Intravenous immunoglobulin: a single-blind trial in children with Lennox–Gastaut syndrome
  publication-title: Neuropediatrics
  contributor:
    fullname: Heilmann
– volume: 153
  start-page: 762
  year: 1994
  end-page: 769
  ident: bib10
  article-title: High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox–Gastaut syndrome: an add-on study
  publication-title: Eur J Pediatr
  contributor:
    fullname: Notermans
– volume: 18
  start-page: 165
  year: 1998
  end-page: 168
  ident: bib13
  article-title: Successful use of intravenous immunoglobulins in Landau–Kleffner syndrome
  publication-title: Pediatr Neurol
  contributor:
    fullname: Casaer
– volume: 359
  start-page: 1522
  year: 2002
  ident: bib17
  article-title: Polyclonal intravenous immunoglobulin to prevent brain injury in preterm infants
  publication-title: Lancet
  contributor:
    fullname: Isaacs
– volume: 18
  start-page: 379
  year: 2003
  end-page: 382
  ident: bib5
  article-title: Intravenous immunoglobulin as adjunctive therapy for juvenile spasms
  publication-title: J Child Neurol
  contributor:
    fullname: Rho
– volume: 38
  start-page: 489
  year: 1997
  end-page: 494
  ident: bib12
  article-title: Landau–Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report
  publication-title: Epilepsia
  contributor:
    fullname: Mikati
– volume: 28
  start-page: 270
  year: 2006
  end-page: 274
  ident: bib18
  article-title: Impact of IVIG on the interaction between activated T cells and microglia
  publication-title: Neurol Res
  contributor:
    fullname: Yong
– volume: 41
  start-page: 880
  year: 2000
  end-page: 886
  ident: bib14
  article-title: Successful use of intravenous immunoglobulin as initial monotherapy in Landau–Kleffner syndrome
  publication-title: Epilepsia
  contributor:
    fullname: Saab
– volume: 22
  start-page: 797
  year: 2008
  end-page: 803
  ident: bib20
  article-title: The role of cytokines in the pathophysiology of epilepsy
  publication-title: Brain Behav Immun
  contributor:
    fullname: Ravizza
– volume: 120
  start-page: 376
  year: 1992
  end-page: 380
  ident: bib16
  article-title: Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood
  publication-title: J Pediatr
  contributor:
    fullname: Burns
– volume: 24
  start-page: S239
  year: 2003
  end-page: S243
  ident: bib6
  article-title: Rasmussen’s syndrome
  publication-title: Neurol Sci
  contributor:
    fullname: Granata
– volume: 38
  start-page: 301
  year: 1996
  ident: 10.1016/j.yebeh.2009.10.020_bib3
  article-title: Immune globulin treatment in intractable epilepsy of childhood
  publication-title: Turk J Pediatr
  contributor:
    fullname: Türkay
– volume: 21
  start-page: 87
  year: 1990
  ident: 10.1016/j.yebeh.2009.10.020_bib9
  article-title: Intravenous immunoglobulin: a single-blind trial in children with Lennox–Gastaut syndrome
  publication-title: Neuropediatrics
  doi: 10.1055/s-2008-1071468
  contributor:
    fullname: Illum
– volume: 28
  start-page: 270
  year: 2006
  ident: 10.1016/j.yebeh.2009.10.020_bib18
  article-title: Impact of IVIG on the interaction between activated T cells and microglia
  publication-title: Neurol Res
  doi: 10.1179/016164106X98143
  contributor:
    fullname: Janke
– volume: 37
  start-page: 47
  year: 2006
  ident: 10.1016/j.yebeh.2009.10.020_bib19
  article-title: Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis
  publication-title: J Clin Virol
  doi: 10.1016/j.jcv.2006.05.009
  contributor:
    fullname: Wang
– volume: 34
  start-page: 816
  year: 2002
  ident: 10.1016/j.yebeh.2009.10.020_bib11
  article-title: Intravenous treatment with immunoglobulins in epileptic syndromes which are difficult to control
  publication-title: Rev Neurol
  contributor:
    fullname: Espinosa Zacarías
– volume: 359
  start-page: 1522
  year: 2002
  ident: 10.1016/j.yebeh.2009.10.020_bib17
  article-title: Polyclonal intravenous immunoglobulin to prevent brain injury in preterm infants
  publication-title: Lancet
  doi: 10.1016/S0140-6736(02)08446-5
  contributor:
    fullname: Tarnow-Mordi
– volume: 38
  start-page: 489
  year: 1997
  ident: 10.1016/j.yebeh.2009.10.020_bib12
  article-title: Landau–Kleffner syndrome: consistent response to repeated intravenous gamma-globulin doses: a case report
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.1997.tb01740.x
  contributor:
    fullname: Fayad
– volume: 120
  start-page: 376
  year: 1992
  ident: 10.1016/j.yebeh.2009.10.020_bib16
  article-title: Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral blood
  publication-title: J Pediatr
  doi: 10.1016/S0022-3476(05)80900-X
  contributor:
    fullname: Finberg
– volume: 26
  start-page: 298
  year: 2002
  ident: 10.1016/j.yebeh.2009.10.020_bib21
  article-title: Efficacy of intravenous immunoglobulin in Landau-Kleffner syndrome
  publication-title: Pediatr Neurol.
  doi: 10.1016/S0887-8994(01)00402-7
  contributor:
    fullname: Mikati
– volume: 7
  start-page: 377
  year: 2005
  ident: 10.1016/j.yebeh.2009.10.020_bib7
  article-title: Management of Landau–Kleffner syndrome
  publication-title: Paediatr Drugs
  doi: 10.2165/00148581-200507060-00006
  contributor:
    fullname: Mikati
– volume: 18
  start-page: 165
  year: 1998
  ident: 10.1016/j.yebeh.2009.10.020_bib13
  article-title: Successful use of intravenous immunoglobulins in Landau–Kleffner syndrome
  publication-title: Pediatr Neurol
  doi: 10.1016/S0887-8994(97)00157-4
  contributor:
    fullname: Lagae
– volume: 24
  start-page: S239
  year: 2003
  ident: 10.1016/j.yebeh.2009.10.020_bib6
  article-title: Rasmussen’s syndrome
  publication-title: Neurol Sci
  doi: 10.1007/s10072-003-0086-2
  contributor:
    fullname: Granata
– volume: 153
  start-page: 762
  year: 1994
  ident: 10.1016/j.yebeh.2009.10.020_bib10
  article-title: High-dose intravenous immunoglobulin treatment in cryptogenic West and Lennox–Gastaut syndrome: an add-on study
  publication-title: Eur J Pediatr
  doi: 10.1007/BF01954498
  contributor:
    fullname: Van Engelen
– volume: 41
  start-page: 880
  year: 2000
  ident: 10.1016/j.yebeh.2009.10.020_bib14
  article-title: Successful use of intravenous immunoglobulin as initial monotherapy in Landau–Kleffner syndrome
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1157.2000.tb00257.x
  contributor:
    fullname: Mikati
– volume: 18
  start-page: 379
  year: 2003
  ident: 10.1016/j.yebeh.2009.10.020_bib5
  article-title: Intravenous immunoglobulin as adjunctive therapy for juvenile spasms
  publication-title: J Child Neurol
  doi: 10.1177/08830738030180061001
  contributor:
    fullname: Bingel
– volume: 9
  start-page: 422
  year: 1987
  ident: 10.1016/j.yebeh.2009.10.020_bib8
  article-title: Immunoglobulin therapy in the West syndrome
  publication-title: Brain Dev
  doi: 10.1016/S0387-7604(87)80117-1
  contributor:
    fullname: Ariizumi
– volume: 15
  start-page: 893
  year: 2008
  ident: 10.1016/j.yebeh.2009.10.020_bib1
  article-title: EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
  publication-title: Eur J Neurol
  doi: 10.1111/j.1468-1331.2008.02246.x
  contributor:
    fullname: Elovaara
– volume: 24
  start-page: 162
  year: 1994
  ident: 10.1016/j.yebeh.2009.10.020_bib2
  article-title: Treatment of refractory epilepsy with intravenous immunoglobulins: results of the first double-blind/dose finding clinical study
  publication-title: Int J Clin Lab Res
  doi: 10.1007/BF02592447
  contributor:
    fullname: Van Rijckevorsel-Harmant
– volume: 48
  start-page: 1739
  year: 2007
  ident: 10.1016/j.yebeh.2009.10.020_bib4
  article-title: Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2007.01134.x
  contributor:
    fullname: Billiau
– volume: 50
  start-page: 1517
  year: 2009
  ident: 10.1016/j.yebeh.2009.10.020_bib15
  article-title: Clinical spectrum and medical treatment of children with electrical status epilepticus in sleep (ESES)
  publication-title: Epilepsia
  doi: 10.1111/j.1528-1167.2008.01891.x
  contributor:
    fullname: Kramer
– volume: 22
  start-page: 797
  year: 2008
  ident: 10.1016/j.yebeh.2009.10.020_bib20
  article-title: The role of cytokines in the pathophysiology of epilepsy
  publication-title: Brain Behav Immun
  doi: 10.1016/j.bbi.2008.03.009
  contributor:
    fullname: Vezzani
SSID ssj0011531
Score 2.1659608
SecondaryResourceType review_article
Snippet Abstract Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new...
Our aim was to investigate the long term effectiveness of intravenous immunoglobulin (IVIG) against intractable childhood epilepsy in the era of new...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 90
SubjectTerms Adolescent
Child
Child, Preschool
Epilepsy
Epilepsy - classification
Epilepsy - drug therapy
Epilepsy - physiopathology
Female
Generalized seizures
Humans
Immunoglobulins, Intravenous - administration & dosage
Immunologic Factors - administration & dosage
Infantile spasms
Intravenous gamma globulin
Lennox–Gastaut syndrome
Longitudinal Studies
Male
Multivariate Analysis
Neurology
Partial seizures
Therapy
West syndrome
Young Adult
Title Intravenous immunoglobulin therapy in intractable childhood epilepsy: Open-label study and review of the literature
URI https://www.clinicalkey.es/playcontent/1-s2.0-S1525505009006027
https://dx.doi.org/10.1016/j.yebeh.2009.10.020
https://www.ncbi.nlm.nih.gov/pubmed/20004620
https://search.proquest.com/docview/733889222
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED-aFMZeRvedtgt62OO0xLJi2X0roSXZ1jK2BfIm9GWWUZwwZ4W89G_vnWUHRrc97M0IS7buTncn6e53AG8J38WlieFp8AWXNje8MNLwJJXeZA0mOiUKX11ns4X8sJwsD2Da5cJQWGWr-6NOb7R12zJqqTnarFajr1S5B-03OgkEKiJUDw7RHEnZh8Pz-cfZ9f4yARd1hE0VE04dOvChJsxrh7P4HnErKcqL6n7_2UD9zQFtDNHlETxpPUh2Hn_yKRyE6hk8umrvyJ9DPafz2tsGe5WtKP1jTagfFHHOYrbVjuHjit5yW8qcYq7DN2Zhg1piU-_OGEWacBSRcMMaCFpmKs9iogtblzQSu9lDMr-AxeXFt-mMt6UVuJOq2HIVrEJOlN4YlQiT2TRNfVpOfG5LJaRRwXsTvLXo8OTIT1e64IScBJV4KWxIX0K_WlfhNbDEJ452tpm1OKCwRong0OqNHaoCm7sBvOvoqTcRQUN3oWU_dEN-qoVZUCOSfwCqo7nukkNRnYW6XVu1TnQt9Fg_4P8Asn3P30RIo3X49ydZx1uNi4tuTEwVkEla4QY-L9CFGsCryPP9FESTdyvGx__71RN4HCMR6DjnFPrbn7_CG3RwtnYIvfd3yRDFePrl0-dhK873JpP9Wg
link.rule.ids 315,786,790,4521,24144,27957,27958,45620,45714
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fT9swED6xIm17mYBtrGMDP-wRq43jxMneEBpqB-3LQOLN8q9oRSitSDep__3u4qQSYtsDb5EVO_GdfXe27_sM8IX4XVyaGJ4GX3JpC8NLIw1PUulN3nKiE1B4Ns8nN_L7bXa7A-c9FobSKjvbH216a627klEnzdFqsRj9oJt70H9jkECkIkK9gF2ZqUQOYPdsejmZbw8TcFJH2lSRcarQkw-1aV4b7MXPyFtJWV507_ffHdS_AtDWEV3swZsugmRn8Sf3YSfUB_By1p2Rv4VmSvu1v1vuVbYg-MeSWD8o45xFtNWG4eOC3nJrQk4x1_Mbs7BCK7FqNl8ZZZpwHCLhnrUUtMzUnkWgC1tW1BK731Iyv4Obi2_X5xPeXa3AnVTlmqtgFWqi8saoRJjcpmnq0yrzha2UkEYF703w1mLAU6A-XeWCEzILKvFS2JC-h0G9rMMHYIlPHK1sc2uxQWGNEsGh1xs7NAW2cEM47eWpV5FBQ_epZXe6FT_dhVlSIYp_CKqXue7BoWjOQtPNrUYnuhF6rJ_ofwj5tuajIaTRO_z_k6zXrcbJRScmpg6oJK1wAV-UGEIN4TDqfNsF0eJuxfjjc796Aq8m17MrfTWdXx7B65iVQFs7n2CwfvgVPmOws7bH3WD-A1Pl_bc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Intravenous+immunoglobulin+therapy+in+intractable+childhood+epilepsy%3A+Open-label+study+and+review+of+the+literature&rft.jtitle=Epilepsy+%26+behavior&rft.au=Mikati%2C+Mohamad+A&rft.au=Kurdi%2C+Rana&rft.au=El-Khoury%2C+Ziad&rft.au=Rahi%2C+Amal&rft.date=2010-01-01&rft.issn=1525-5050&rft.eissn=1525-5069&rft.volume=17&rft.issue=1&rft.spage=90&rft.epage=94&rft_id=info:doi/10.1016%2Fj.yebeh.2009.10.020&rft.externalDocID=1_s2_0_S1525505009006027
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15255050%2FS1525505009X00144%2Fcov150h.gif